Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1481 | Thyroid (non-cancer) | ECE2017

Lymph node categorization as a prognostic factor in a historical series of medullary thyroid cancer cases within a regional hospital

Moreno Nerea Aguirre , Gonzalez Elena Fernandez , Mena Sandra Campos , Azpiroz Monica Marazuela , Vargas Marcos Lahera

Introduction: Medullary thyroid cancer (MTC) TNM classification categorizes lymph nodes (LN) according to their location, but does not consider number and size of LN.Objective: To analyze the relationship between number and size of LN in MCT persistent disease (PD).Material and methods: Retrospective study of patients with MTC followed up in a regional hospital from 1985 to 2015. The main variables (expressed as qualitative in freq...

ea0063p946 | Diabetes, Obesity and Metabolism 3 | ECE2019

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

Peris Begona Pla , Sanchez Clara Marijuan , Moreno Nerea Aguirre , Alday Inigo Hernando , Blanco Sara Jimenez , Nunez Miguel Sampedro , Moreno Rosa Giron , Azpiroz Monica Marazuela , Martin Alfonso Arranz

Introduction: Abnormal glucose metabolism (AGM) is the most common extra-pulmonary comorbidity in people with cystic fibrosis (CF) and has a high negative impact on the underlying disease. Elevated postprandial glucose level is usually the first manifestation, which is traditionally detected by 75-gram oral glucose tolerance test (OGTT). The aim of this study was to evaluate glycemic pattern during continuous glucose monitoring (CGM) in patients with impaired glucose metabolis...

ea0063p1216 | Thyroid 3 | ECE2019

Real-life experience with lenvatinib in iodine-refractory thyroid cancer in a terciary hospital

Sanchez Clara Marijuan , Peris Begona Pla , Moreno Nerea Aguirre , Alday Inigo Hernando , Blanco Sara Jimenez , Azpiroz Monica Marazuela , Vargas Marcos Lahera

Introduction: Lenvatinib is an oral tyrosine kinase inhibitor (TKI) used for treatment of progressive, clinically significant or symptomatic disease in patients with iodine-refractory differentiated thyroid cancer (DTC).Objective: To describe our clinical experience with lenvatinib in patients with iodine-refractory differentiated thyroid cancer.Methods: Restrospective cohort study of patients with iodine-refractory differentiated ...

ea0049ep574 | Diabetes complications | ECE2017

Characteristics of patients with cystic fibrosis and hydrocarbon alteration in an adult unit

Gonzalez Elena Fernandez , Moreno Nerea Aguirre , Caceres Layla Diab , Gutierrez Carmen Acosta , Ramos-Levi Ana , Nunez Miguel Sampedro , Moreno Isabel Huguet , Azpiroz Monica Marazuela , Moreno Rosa Maria Giron , Martin Alfonso Arranz

Introduction: Hydrocarbon Alteration (HA) is considered as the most common complication in Cystic Fibrosis (CF) and is related to a further deterioration of the lung function and the nutritional status.Objective: Analyze the prevalence of HA in patients with CF in an adult unit and its relationship with pulmonary complications.Material and methods: We conducted a retrospective study with 71 patients of our CF unit (age 30+/−9...

ea0049ep1072 | Pituitary - Clinical | ECE2017

Risk factors for progression of the surgical remnant of non-functioning pituitary adenomas in patients treated with dopamine agonists

Gonzalez Elena Fernandez , Nunez Miguel Sampedro , Levi Ana Ramos , Caon Ana Rabe , Hughet Isabel , Moreno Nerea Aguirre , Sanchez Clara Marijuan , Peris Begona Pla , Nieto Angeles Maillo , Andres Alicia Vicuna , Flores Pedro Martinez , Azpiroz Monica Marazuela

Introduction: Surgery is the treatment of choice for non-functioning pituitary adenomas (NFPA), but remnants are frequently observed. Management of these remnants include observation (OBS), radiotherapy (RT) and/or dopamine agonist (DA) therapy. In this study, we evaluate the progression-free survival (PFS) of NFPA with postoperative remnant and the potential factors involved.Methods: We performed a single-center ambispective study of a cohort of 72 pati...

ea0056p1166 | Thyroid cancer | ECE2018

Descriptive analysis of papillary thyroid microcarcinomas in a single-center

Gonzalez Elena Fernandez , Moreno Isabel Huguet , Munoz Jose Luis , Moreno Nerea Aguirre , Peris Begona Pla , Sanchez Clara Marijuan , Castro Marta Araujo , Ramos-Levi Ana , Azpiroz Monica Marazuela , Ramirez Manuel Luque , Vargas Marcos Lahera

Introduction: The incidence of papillary thyroid microcarcinomas (MPT, max diameter≤10 mm) has increased in recent years. Most have a very good prognosis but some have growth during follow-up, lymph node and / or distant metastases.Material and methods: We performed a single-center, retrospective cohort study, n=114 patients (86% women, average age 48.3 years), diagnosed with MPT between 1998 and 2012. Risk stratification system (ATA 2015): 10 high...